Johnson & Johnson (J&J), a leading multinational corporation, is poised for substantial growth in 2023, driven by its breakthrough cancer…
U.S. FDA Classifies Recall of J&J’s Electrosurgical Tools as Most Serious: An In-Depth Analysis
In a recent development, the U.S. Food and Drug Administration (FDA) has taken a significant step by classifying the recall…
J&J’s $8.9 Billion Talc Settlement Faces US Bankruptcy Test
Johnson & Johnson (J&J), the multinational pharmaceutical and consumer goods company, recently made headlines with its historic $8.9 billion talc…